Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

PROMETIC (1)


symetry121
(0)

56029 Reads | 19 Comments | 3 People call this a favourite



  • T.PLI:NR:PLI SECURES $20 MILLION FOLLOW-ON INVESTMENT FROM THOMVEST SEED CAPITAL INC.


    287 Reads | 1 Comment | August 1, 2014


  • T.PLI:ProMetic signs $2.7-million deal with existing client


    301 Reads | 0 Comments | July 24, 2014

    ProMetic signs $2.7-million deal with existing client 2014-07-24 09:00 ET - News Release   Dr. Steve Burton reports PROMETIC ENTERS INTO NEW PRODUCT PROGRAM WITH AN EXISTING MULTINATIONAL CLIENT ProMetic Life Sciences Inc.'s United Kingdom subsidiary, ProMetic Biosciences Ltd., has signed an agreement with one of its existing multinational clients, a global leader in the...


  • T.PLI:Canaccord ups price targe to 2.25$


    509 Reads | 0 Comments | July 11, 2014

    Prometic Life Sciences Price Target Increased to C$2.25 by Analysts at Canaccord Genuity (PLI) Posted by Shane Hupp on Jul 11th, 2014 // No Comments Canaccord Genuity lifted their price objective on shares of Prometic Life Sciences (TSE:PLI) from C$2.00 to C$2.25 in a research note issued on Friday. The firm currently has a “buy” rating on the stock. Canaccord Genuity&rsquo...


  • T.PLI:NR:COMMERCIAL LAUNCH OF FIBRINOGEN IN THE FOURTH QUARTER OF 2014


    298 Reads | 0 Comments | July 10, 2014

    PROMETIC TO COMMERCIALLY LAUNCH FIBRINOGEN IN THE FOURTH QUARTER OF 2014 LAVAL, QUEBEC, CANADA, - July 10, 2014 - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation") announced today that it will launch fibrinogen for commercial sales during the fourth quarter of 2014 after its successful scale-up at its Laval based plasma purification...


  • T.PLI: july 7th, Hybridan update, full report


    394 Reads | 0 Comments | July 8, 2014

    link: https://docs.google.com/file/d/0B_utQzyDsrBNdThEYTVnT3FEWTA/edit thanks to francois.


  • T.PLI:Russell Global Index to include PLI!


    321 Reads | 1 Comment | July 7, 2014

    https://www.russell.com/indexes/americas/tools-resources/reconstitution/additions-deletions.page RECONSTITUTIN ADDITIONS AS RUSSELL GLOBAL OF JUNE 27, 2014 Source: https://www.russell.com/indexes/americas/tools-resources/reconstitution/additions-deletions.page Russell Global.. Additions ...PROMETIC LIFE SCIENCES INC. Canada Health Care Read more at http://www.stockhouse.com...


  • T.PLI:ProMetic Life Sciences : Finalizes PBI-4050 Phase I Clinical


    369 Reads | 1 Comment | June 26, 2014

    small article i found on the latest news: http://www.4-traders.com/PROMETIC-LIFE-SCIENCES-IN-1411267/news/ProMetic-Life-Sciences--Finalizes-PBI-4050-Phase-I-Clinical-Trial-18644770/ ProMetic Life Sciences : Finalizes PBI-4050 Phase I Clinical Trial 06/26/2014 | 12:46am US/Eastern Recommend: 0 ProMetic Life...


  • T.PLI:some of the catalysts incoming...


    545 Reads | 1 Comment | June 24, 2014

    agalea1979   User Actions   June 23, 2014 - 09:17 PM   303 Reads | Post# 22687802 Rate this post   v Revenues and things to come... Recap from previous news releases: 1-   Baseline revenues in 2014 to...